Compare MXCT & FTCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MXCT | FTCI |
|---|---|---|
| Founded | 1999 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.2M | 122.4M |
| IPO Year | 2021 | 2021 |
| Metric | MXCT | FTCI |
|---|---|---|
| Price | $1.10 | $2.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $4.11 | ★ $8.90 |
| AVG Volume (30 Days) | 325.0K | ★ 406.5K |
| Earning Date | 11-04-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $33,026,000.00 | ★ $99,687,000.00 |
| Revenue This Year | N/A | $34.96 |
| Revenue Next Year | $18.24 | $49.66 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 110.51 |
| 52 Week Low | $0.64 | $1.99 |
| 52 Week High | $1.86 | $12.75 |
| Indicator | MXCT | FTCI |
|---|---|---|
| Relative Strength Index (RSI) | 41.47 | 39.85 |
| Support Level | $1.11 | $2.00 |
| Resistance Level | $1.16 | $2.78 |
| Average True Range (ATR) | 0.05 | 0.24 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 15.38 | 12.66 |
MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.
FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.